Recent News

Adding a Tumor Bed Boost to Whole-Breast Irradiation for Ductal Carcinoma in Situ

Androgen Receptor Modulator in ER-Positive/AR-Positive Breast Cancer

Are Individuals With Multiple Sclerosis at Higher Risk of Developing Breast Cancer?

IPATunity130 Trial of Ipatasertib Plus Paclitaxel for Advanced Triple-Negative Breast Cancer

Oral Contraceptives and Risk of Breast Cancer

Tesetaxel Plus Reduced-Dose Capecitabine in Metastatic Breast Cancer

FDA Brief: Zenocutuzumab Granted Fast Track Designation for NRG1 Fusion Cancers

Shortened Course of Radiotherapy for Breast Cancer After Surgery

Enumeration of CTCs in Predicting Therapeutic Outcomes in Metastatic Breast Cancer

Preclinical Trial Explores Anti–PD-1 Strategies for Triple-Negative Breast Cancer

Recognizing Adverse Symptoms in Patients Undergoing Breast Radiotherapy

Trop-2 Expression and Sacituzumab Govitecan in Triple-Negative Breast Cancer

SABCS 2020: Pembrolizumab Plus Chemotherapy in Metastatic Triple-Negative Breast Cancer

Comparison of Number of Fractions of Accelerated Partial Breast Irradiation

Margetuximab-cmkb in Combination With Chemotherapy Approved by FDA for Metastatic Breast Cancer

SABCS 2020: Patient-Reported Outcomes With Atezolizumab Plus Chemotherapy in Triple-Negative Breast Cancer

Patient-Reported Outcomes After Switch to Endocrine Therapy in Metastatic Breast Cancer

SABCS 2020: Provider Survey on Managing Early-Stage Breast Cancer Amid COVID-19

SABCS 2020: Initial PENELOPE-B Results With Palbociclib-Based Therapy for Primary Breast Cancer

SABCS 2020: Does Breast Cancer Influence Mortality From COVID-19?

Is Increased Adiposity Causally Protective for Breast Cancer?

ESMO Asia 2020: MONARCH 2 Update on Abemaciclib Plus Fulvestrant in East Asian Patients With Breast Cancer

De-escalated Weekly Dose of Palliative Breast Radiotherapy

Final Overall Survival Results From nextMONARCH Trial in Metastatic Breast Cancer

ESMO Asia 2020: Subgroup Analysis of KEYNOTE-522 Supports Use of Pembrolizumab in Triple-Negative Breast Cancer

SITC 2020: Cyclophosphamide Prior to Pembrolizumab in Metastatic Triple-Negative Breast Cancer

ASTRO 2020: Risk of Radiation-Induced Heart Disease in Patients Treated for Breast Cancer

Novel CDK4/6 Inhibitor Plus Fulvestrant Under Study in Advanced Breast Cancer

Pembrolizumab Plus Chemotherapy Receives Accelerated Approval in Triple-Negative Breast Cancer

Early Breast Cancer: Risk-Adapted Targeted Intraoperative Radiotherapy During Lumpectomy

ASTRO 2020: Olaparib Plus Radiotherapy for Advanced Triple-Negative Breast Cancer

Risk of Breast Cancer and Frequency of Pathogenic Variants in Older Women

ASTRO 2020: Initial 2-Year Results of Comparison of Breast Irradiation Therapies

Study Finds Potential Therapeutic Benefit of Honeybee Venom in Breast Cancer Cells

Reduced Dose of Eribulin in Elderly Patients With Advanced Breast Cancer

Global Trends in Premenopausal and Postmenopausal Breast Cancers

North African Breast Cancer Study: Body Image and Sexual Function After Mastectomy

Four-Stranded DNA Structures Identified in Breast Cancer Cells

EBCC 12: Long-Term Survival Outcomes From Phase III Trial in HER2-Positive Breast Cancer

COVID-19 and Breast Cancer Care: Are Younger Patients at Higher Risk of Treatment Delays?

ESMO 2020: Adding Atezolizumab to Chemotherapy Under Study in Triple-Negative Breast Cancer

ESMO 2020: Can Immunotherapy Enhance Effects of Chemotherapy in Triple-Negative Breast Cancer?

ESMO 2020: BRCA Mutations and Treatment Outcomes in Metastatic Breast Cancer

Can Liquid Biopsy Predict Disease Relapse in Triple-Negative Breast Cancer?

ESMO 2020: In-Home Administration of Subcutaneous Trastuzumab Via Single-Use Injection

ESMO 2020: Comparing Neoadjuvant Chemotherapy Regimens in High-Risk Early Breast Cancer

ESMO 2020: Adding Abemaciclib to Hormonal Therapy in High-Risk Early Breast Cancer

IGCS 2020: Does the p53 Protein Have Prognostic Value in Breast Cancer?

Breast Cancer and COVID-19: Treatment Lessons Learned

FDA Issues Alert About Concerns With Atezolizumab Plus Paclitaxel in Triple-Negative Breast Cancer

Oral Paclitaxel and Encequidar Receives FDA Priority Review in Metastatic Breast Cancer

Dietary Acid Load and Smoking History in Breast Cancer Survivors

Early Breast Cancer Management During the COVID-19 Pandemic: A Case Report

Impact of Surgical Treatment Delay for Patients With Early-Stage Breast Cancer

Exploratory Final Analysis of T-DM1 in Metastatic Breast Cancer: KAMILLA Trial

UK Study Focuses on Survival Outcomes in Breast Cancer During the COVID-19 Pandemic

FDA Amends Guidelines for Male Breast Cancer Clinical Trial Enrollment

Is Pregnancy Safe in Women With Early BRCA-Mutated Breast Cancer?

Potential Link Between Insulin Resistance and Racial Disparities in Breast Cancer Prognosis

Breast Cancer Screening for Childhood Cancer Survivors With a History of Chest Radiotherapy

AACR COVID-19: Using MammaPrint Assay to Guide Chemotherapy Decisions for Breast Cancer

AACR COVID-19: Balancing Risks and Benefits of Surgery for Breast Cancer

FDA Accepts Two Applications for Pembrolizumab in Triple-Negative Breast Cancer

FDA Approves Breast Cancer Companion Diagnostic for Trastuzumab Therapy

AACR COVID-19: Adjustments in Use of CDK4/6 Inhibitors for Metastatic Breast Cancer

Collaborative Palliative Care Intervention for Women With Metastatic Breast Cancer